Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.1.2025Olikla s.r.o. (OLK)76587Solusin 50 mikrogramov/ml očné roztokové kvapky (int opo 3x2,5 ml (fľ.LDPE))4.7.2024R
 17.1.2025Olikla s.r.o. (OLK)76587Solusin 50 mikrogramov/ml očné roztokové kvapky (int opo 3x2,5 ml (fľ.LDPE))8.7.2024O
 17.1.2025Zentiva, k.s. (ZNT-1)7283CLopridam 4 mg/1,25 mg/5 mg (tbl 90x4 mg/1,25 mg/5 mg (blis.OPA/Al/PVC/Al))20.1.2025O
 17.1.2025Zentiva, k.s. (ZNT-1)5785EDaroxomb 110 mg (cps dur 180 (3x60x1) x110 mg (blis.Al/OPA/Al/PVC - jednotk.bal. - multibal.))14.1.2025U
 17.1.2025Zentiva, k.s. (ZNT-1)5790EDaroxomb 150 mg (cps dur 180 (3x60x1) x150 mg (blis.Al/OPA/Al/PVC - jednotk.bal. - multibal.))14.1.2025U
 17.1.2025Zentiva, k.s. (ZNT-1)6859ENilotinib Zentiva 150 mg (cps dur 112 (4x28)x150 mg (blis.PVC/PE/PVdC//Al - multibal.))14.1.2025U
 17.1.2025Desitin Arzneimitttel GmbH (DET)2468BPhenaemal (tbl 50x100 mg (obal PE biely))20.1.2025R
 16.1.2025Novartis Europharm Limited (NEH-IE)2619ELocametz 25 mikrogramov kit na rádiofarmakum (kit 1x25 µg (liek.inj.skl.))17.1.2025U
 16.1.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3270BPramipexol Teva Pharma 0,52 mg (tbl plg 30x0,52 mg (blis.OPA/Al/PVC/Al))16.1.2025O
 16.1.2025GlaxoSmithKline Dungarvan Ltd. (GAG-IRL-1)13973Flixotide 125 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))10.1.2025R
 16.1.2025GlaxoSmithKline (Ireland) Limited (GAG-IE-2)94814Ventolin (sol neb 1x20 ml/100 mg (liek.skl.))13.1.2025O
 16.1.2025GlaxoSmithKline Trading Services Limited (GAG-IRL-3)90778Bactroban (ung der 1x15 g (tuba Al))13.1.2025O
 16.1.2025N.V. Organon (ORG-NL)35965INEGY 10 mg/20 mg tablety (tbl 98x10 mg/20 mg (blis.PCTFE/PVC/Al))16.1.2025O
 16.1.2025Merck Europe B.V. (MCK-NL)42192Ovitrelle 250 mikrogramov/0,5 ml, injekčný roztok v naplnenej injekčnej striekačke (sol iru 1x0,5 ml/250 µg (striek.inj.napl.skl. + inj.ihla))15.1.2025R
 15.1.2025N.V. Organon (ORG-NL)1572BATOZET 10 mg/20 mg filmom obalené tablety (tbl flm 30x10 mg/20 mg (blis.OPA/Al/PVC/Al))14.3.2025Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)